RecruitingPhase 3NCT06399705

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities


Sponsor

Weill Medical College of Cornell University

Enrollment

600 participants

Start Date

Oct 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an open-heart operation in which healthy blood vessels from inside the chest, leg, and/or forearm are used to "bypass" the blockages (like a detour). Outcomes will be measured by comparing survival and improvement in quality-of-life.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patient must identify as a minority
  • Patient is at least 18 years old.
  • Multivessel or left main CAD is present for which revascularization is intended and for which there is equipoise between CABG and PCI according to local Heart Team assessment.
  • Ability to provide written informed consent and comply with all follow-up procedures, including QOL questionnaires.

Exclusion Criteria7

  • ST-segment elevation MI within 3 days
  • Cardiogenic shock
  • Prior PCI within 1 year or any prior CABG anytime
  • Planned hybrid revascularization (PCI after CABG or CABG after PCI)
  • Planned single vessel revascularization (other than isolated left main disease)
  • Need for any cardiac surgical or interventional procedure other than coronary revascularization at the present time or anticipated within 3 years
  • Pregnancy (women of child-bearing potential must have a negative pregnancy test within 1 week before randomization) or intent to become pregnant within 1 year after randomization Unable to tolerate, obtain or comply with dual antiplatelet therapy for at least 3 months if presentation with stable CAD or 6 months if presentation with a troponin-positive acute coronary syndrome Current participation in another investigational drug or device study that has not reached its primary endpoint Life-expectancy less than 3 years due to concomitant non-cardiac conditions Any condition(s) are present that are likely to interfere with the study protocol procedures including medication adherence and follow-up through 10 years (e.g. mental disability, substance abuse, anticipated international relocation, etc.)

Interventions

PROCEDURECoronary artery bypass grafting

Coronary artery bypass grafting (CABG), also called heart bypass surgery, is a medical procedure to improve blood flow to the heart.

PROCEDUREPercutaneous coronary intervention

Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat the blockages in a coronary artery; it opens up narrowed or blocked sections of the artery, restoring blood flow to the heart


Locations(18)

Adventist Health Glendale

Glendale, California, United States

Emory University

Atlanta, Georgia, United States

Ascension St. Vincent Cardiovascular Research Institute

Carmel, Indiana, United States

Baptist Health Lexington

Lexington, Kentucky, United States

Baptist Health Louisville

Louisville, Kentucky, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Englewood Hospital

Englewood, New Jersey, United States

NewYork-Presbyterian Hospital - Queens

Flushing, New York, United States

Icahn School of Medicine - Mount Sinai Morningside

New York, New York, United States

Icahn School of Medicine - Mount Sinai Hospital

New York, New York, United States

Columbia University Irving Medical Center/NewYork-Presbyterian Hospital

New York, New York, United States

Weill Cornell Medicine/NewYork-Presbyterian Hospital

New York, New York, United States

Westchester Medical Center

Valhalla, New York, United States

Duke University

Durham, North Carolina, United States

Ohio State University

Columbus, Ohio, United States

Methodist Le Bonheur Healthcare

Memphis, Tennessee, United States

Ascension Saint Thomas Hospital

Nashville, Tennessee, United States

Baylor Scott and White

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06399705


Related Trials